Los puntos clave no están disponibles para este artículo en este momento.
Acknowledging the dynamic and evolving nature of less-invasive aortic valve therapies, further refinements of clinical research processes are required. The adoption of these updated and newly proposed VARC-3 endpoints and definitions will ensure homogenous event reporting, accurate adjudication, and appropriate comparisons of clinical research studies involving devices and new therapeutic strategies.
“The establishment of the VARC-3 definition in 2021 enabled consistent reporting of durability outcomes and more meaningful comparisons between TAVI and SAVR.”
Généreux et al. (Mon,) studied this question.